KLRK1 and B-cell chronic lymphocytic leukemia: In particular, the percentage of NKG2D-positive NK cells was reduced by 51% amongst patients with B-CLL (mean ± SEM B-CLL 43.1% ± 2.7% vs HD 86.6% ± 2.7%; p < 0.001; Figure 2B).